Determinants in Initial Treatment Choice for Diabetic Macular Edema-Reference-Cited by-同舟云学术

登录注册会员服务联系我们

Determinants in Initial Treatment Choice for Diabetic Macular Edema

Published:2020-01 Issue:1 Volume:4 Page:41-48
ISSN:2468-6530
Container-title:Ophthalmology Retina
language:en
Short-container-title:Ophthalmology Retina

Author:

VanderBeek Brian L.,Scavelli Kurt,Yu Yinxi

Funder

National Institutes of Health

University of Pennsylvania

Research to Prevent Blindness

Paul and Evanina Mackall Foundation

Publisher

Elsevier BV

Subject

Ophthalmology

Reference31 articles.

1. Intravitreal bevacizumab plus grid laser photocoagulation or intravitreal bevacizumab or grid laser photocoagulation for diffuse diabetic macular edema: results of the Pan-American Collaborative Retina Study Group at 24 months;Arevalo;Retina,2013

2. A 2-year prospective randomized controlled trial of intravitreal bevacizumab or laser therapy (BOLT) in the management of diabetic macular edema: 24-month data: report 3;Rajendram;Arch Ophthalmol,2012

3. Comparison of grid laser, intravitreal triamcinolone, and intravitreal bevacizumab in the treatment of diffuse diabetic macular edema;Sobaci;Ophthalmologica,2012

4. Ranibizumab for Edema of the Macula in Diabetes Study: 3-year outcomes and the need for prolonged frequent treatment;Do;Arch Ophthalmol,2012

5. Intravitreal ranibizumab for diabetic macular edema with prompt versus deferred laser treatment: three-year randomized trial results;Elman;Ophthalmology,2012

Cited by 6 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cost-sharing and adherence, clinical outcomes, health care utilization, and costs: A systematic literature review;Journal of Managed Care & Specialty Pharmacy;2023-01

2. Social Determinants of Health and Impact on Screening, Prevalence, and Management of Diabetic Retinopathy in Adults: A Narrative Review;Journal of Clinical Medicine;2022-11-30

3. An Introduction to Biosimilars for the Treatment of Retinal Diseases: A Narrative Review;Ophthalmology and Therapy;2022-03-12

4. Impacts of high-deductible health plans on patients with diabetes: A systematic review of the literature;Primary Care Diabetes;2021-12

5. Cost-effectiveness of Autonomous Point-of-Care Diabetic Retinopathy Screening for Pediatric Patients With Diabetes;JAMA Ophthalmology;2020-10-01

同舟云学术

1.学者识别学者识别

2.学术分析学术分析

3.人才评估人才评估

"同舟云学术"是以全球学者为主线，采集、加工和组织学术论文而形成的新型学术文献查询和分析系统，可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容，当前同舟云学术共收录了国内外主流学术期刊6万余种，收集的期刊论文及会议论文总量共计约1.5亿篇，并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询！咨询电话：010-8811{复制后删除}0370

www.globalauthorid.com

TOP

Copyright © 2019-2024 北京同舟云网络信息技术有限公司
京公网安备11010802033243号京ICP备18003416号-3